NCT07064486View on ClinicalTrials.gov

A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

PHASE3RecruitingINTERVENTIONAL
Enrollment

477

Participants

Timeline

Start Date

June 11, 2025

Primary Completion Date

March 28, 2026

Study Completion Date

March 28, 2026

Conditions
Type 2 Diabetes (T2DM)
Interventions
DRUG

BGM0504

Administered SC

DRUG

BGM0504

Administered SC

DRUG

Semaglutide

Administered SC

Trial Locations (4)

Unknown

RECRUITING

RS Universitas Indonesia, Depok

RECRUITING

RSUP Fatmawati, Jakarta

RECRUITING

RSUP Persahabatan, Jakarta

RECRUITING

RSUPN Dr. Cipto Mangunkusumo, Jakarta

All Listed Sponsors
lead

BrightGene Bio-Medical Technology Co., Ltd.

INDUSTRY